Lombard Medical Technologies (LSE:LMT) EV-to-EBIT : -10.23 (As of Jun. 07, 2024)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lombard Medical Technologies's Enterprise Value is £84.34 Mil. Lombard Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2012 was £-8.24 Mil. Therefore, Lombard Medical Technologies's EV-to-EBIT for today is -10.23.

The historical rank and industry rank for Lombard Medical Technologies's EV-to-EBIT or its related term are showing as below:

During the past 10 years, the highest EV-to-EBIT of Lombard Medical Technologies was 0.40. The lowest was -2.00. And the median was -0.55.

LSE:LMT's EV-to-EBIT is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 19.78
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Lombard Medical Technologies's Enterprise Value for the quarter that ended in Dec. 2012 was £35.30 Mil. Lombard Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2012 was £-8.24 Mil. Lombard Medical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2012 was -23.36%.

Lombard Medical Technologies EV-to-EBIT Historical Data

The historical data trend for Lombard Medical Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies EV-to-EBIT Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

EV-to-EBIT

Get a 7-Day Free Trial

-0.12

-0.86

-3.15

-1.48

-4.28

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
EV-to-EBIT	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Lombard Medical Technologies's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Lombard Medical Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lombard Medical Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lombard Medical Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lombard Medical Technologies's EV-to-EBIT falls into.

Lombard Medical Technologies EV-to-EBIT Calculation

Lombard Medical Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	84.341	/	-8.244
	=	-10.23

Lombard Medical Technologies's current Enterprise Value is £84.34 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lombard Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2012 was £-8.24 Mil.

Lombard Medical Technologies (LSE:LMT) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lombard Medical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2012 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2012 )	=	EBIT	/	Enterprise Value (Q: Dec. 2012 )
	=	-8.244	/	35.2975
	=	-23.36 %

Lombard Medical Technologies's Enterprise Value for the quarter that ended in Dec. 2012 was £35.30 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lombard Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2012 was £-8.24 Mil.

Lombard Medical Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Lombard Medical Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.